Evaluation of medicine distribution, regulatory privatization, social welfare services and its alternatives

8^th World congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit

June 26-27, 2017 San Diego, USA

Abdeen Mustafa Omer

Ministry of Health and Social Welfare, Sudan

Posters & Accepted Abstracts: J Bioanal Biomed

Abstract :

The strategy of price liberalization and privatization had been implemented in Sudan over the last decade, and had a positive result on government deficit. The investment law which is approved recently has good statements and rules on the above strategy in particular to pharmacy regulations. Under the pressure of the new privatization policy, the government introduced radical changes in the pharmacy regulations. To improve the effectiveness of the public pharmacy, resources should be switched towards areas of need, reducing inequalities and promoting better health conditions. Medicines are financed either through cost sharing or full private. The role of the private services is significant. A review of reform of financing medicines in Sudan is given in this article. Also, it highlights the current drug supply system in the public sector, which is currently responsible for the Central Medical Supplies Public Corporation (CMS). In Sudan, the researchers did not identify any rigorous evaluations or quantitative studies about the impact of drug regulations on the quality of medicines and how to protect public health against counterfeit or low quality medicines, although it is practically possible. However, the regulations must be continually evaluated to ensure the public health which is protected against by marketing high quality medicines rather than commercial interests, and the drug companies are held accountable for their conducts.

Biography :

Email: abdeenomer2@yahoo.co.uk